AGP Executive Report
Last update: 7 hours agoFederal Medical Cannabis: The DEA has granted registrations to more than 900 state-licensed dispensaries in seven states, bringing them under federal rules for the first time. The move could affect compliance costs and tax treatment, but state licenses alone do not qualify businesses. Regulatory Scrutiny: The AMA is urging the FDA to apply drug-approval standards to botanical products, including cannabis, as a GAO report flags weaknesses in federal scheduling procedures. Hemp and CBD: A looming federal hemp redefinition is raising concern among industry veterans about the original CBD market, while proposed restrictions could also threaten hemp-derived THC drinks. State Markets: New York has scrapped cannabis labor-peace requirements and plans for an industry wage board; Massachusetts voters decide today whether to repeal recreational marijuana sales.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
